Caspase-mediated apoptosis in chicken postovulatory follicle regression. 2008

N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
Disease Genetics and Biotechnology Laboratory, Central Avian Research Institute, Izatnagar, 243122 Bareilly, India. drravicari@gmail.com

Chicken postovulatory follicle (POF) regression occurs via the process of apoptosis. However, the signals and initiator pathways responsible for regression of the POF are unknown. In the current study, we examined gene expression patterns of various caspases (caspase-1, -2 and -3) involved in apoptosis by semi-quantitative RT-PCR. The percentage of apoptotic cells during POF regression was also quantified by flow cytometry. Expression of caspase-3 mRNA was noted in the largest preovulatory follicle (F1). However, the initiator caspases (caspase-1 and -2) were not expressed in F1. During the regression of the POF, caspase-3 was activated during initial stages, whereas the initiator caspases were upregulated at the later stages (POF4 and POF5). The percentage of apoptotic cells was significantly higher during the regression of the POF. It might be possible that levels of caspase-3 mRNA do not necessarily reflect the cell's potential for facilitating apoptosis, as activation of the caspase-3 by initiator caspases is required for its function. We presume that both caspase-1 and caspase-2 were key initiators in the regression of chicken POF and that the apoptosis-mediated regression of POFs might be similar to mammalian corpus luteum involution.

UI MeSH Term Description Entries
D010060 Ovulation The discharge of an OVUM from a rupturing follicle in the OVARY. Ovulations
D002645 Chickens Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA. Gallus gallus,Gallus domesticus,Gallus gallus domesticus,Chicken
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006080 Ovarian Follicle An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS. Graafian Follicle,Atretic Follicle,Ovarian Follicles,Atretic Follicles,Follicle, Atretic,Follicle, Graafian,Follicle, Ovarian,Follicles, Atretic,Follicles, Graafian,Follicles, Ovarian,Graafian Follicles
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D020169 Caspases A family of intracellular CYSTEINE ENDOPEPTIDASES that play a role in regulating INFLAMMATION and APOPTOSIS. They specifically cleave peptides at a CYSTEINE amino acid that follows an ASPARTIC ACID residue. Caspases are activated by proteolytic cleavage of a precursor form to yield large and small subunits that form the enzyme. Since the cleavage site within precursors matches the specificity of caspases, sequential activation of precursors by activated caspases can occur. Caspase

Related Publications

N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
November 1991, Endocrinology,
N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
April 2018, Aging,
N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
July 2000, The Journal of experimental zoology,
N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
December 1997, The American journal of pathology,
N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
July 2002, Reproduction (Cambridge, England),
N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
October 2006, FEBS letters,
N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
April 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience,
N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
October 2006, Theriogenology,
N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
September 1998, Poultry science,
N R Sundaresan, and V K Saxena, and K V H Sastry, and D Anish, and M D Marcus Leo, and C Kantaraja, and M Saxena, and K A Ahmed
October 2017, Experimental dermatology,
Copied contents to your clipboard!